TY - JOUR
T1 - Single nucleotide variations encoding missense mutations in G protein-coupled receptors may contribute to autism
AU - van der Westhuizen, Emma T.
N1 - Funding Information:
Emma T van der Westhuizen is funded by a post‐doctoral salary under a Wellcome Trust Collaborative Awards in Science grant (201529/Z/16/Z) to Prof Arthur Christopoulos, Prof Patrick Sexton and Prof Andrew Tobin.
Publisher Copyright:
© 2023 British Pharmacological Society.
PY - 2024/7
Y1 - 2024/7
N2 - Autism is a neurodevelopmental condition with a range of symptoms that vary in intensity and severity from person to person. Genetic sequencing has identified thousands of genes containing mutations in autistic individuals, which may contribute to the development of autistic symptoms. Several of these genes encode G protein-coupled receptors (GPCRs), which are cell surface expressed proteins that transduce extracellular messages to the intracellular space. Mutations in GPCRs can impact their function, resulting in aberrant signalling within cells and across neurotransmitter systems in the brain. This review summarises the current knowledge on autism-associated single nucleotide variations encoding missense mutations in GPCRs and the impact of these genetic mutations on GPCR function. For some autism-associated mutations, changes in GPCR expression levels, ligand affinity, potency and efficacy have been observed. However, for many the functional consequences remain unknown. Thus, further work to characterise the functional impacts of the genetically identified mutations is required.
AB - Autism is a neurodevelopmental condition with a range of symptoms that vary in intensity and severity from person to person. Genetic sequencing has identified thousands of genes containing mutations in autistic individuals, which may contribute to the development of autistic symptoms. Several of these genes encode G protein-coupled receptors (GPCRs), which are cell surface expressed proteins that transduce extracellular messages to the intracellular space. Mutations in GPCRs can impact their function, resulting in aberrant signalling within cells and across neurotransmitter systems in the brain. This review summarises the current knowledge on autism-associated single nucleotide variations encoding missense mutations in GPCRs and the impact of these genetic mutations on GPCR function. For some autism-associated mutations, changes in GPCR expression levels, ligand affinity, potency and efficacy have been observed. However, for many the functional consequences remain unknown. Thus, further work to characterise the functional impacts of the genetically identified mutations is required.
KW - autism spectrum disorder
KW - G protein-coupled receptors
KW - Missense mutation
KW - Single nucleotide variation
UR - https://www.scopus.com/pages/publications/85150599117
U2 - 10.1111/bph.16057
DO - 10.1111/bph.16057
M3 - Review Article
C2 - 36787962
AN - SCOPUS:85150599117
SN - 0007-1188
VL - 181
SP - 2158
EP - 2181
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 14
ER -